Skip to main content
Ayad Hamdan, MD, Hematology, La Jolla, CA

AyadHamdanMD(He/Him)

Hematology La Jolla, CA

Hematologic Oncology

Clinical Professor of Medicine

Dr. Hamdan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hamdan's full profile

Already have an account?

  • Office

    3855 Health Sciences Dr
    # 960
    La Jolla, CA 92093
    Phone+1 858-822-6600
    Fax+1 858-822-6844

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2005 - 2008
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • MA State Medical License
    MA State Medical License 2008 - 2020
  • OH State Medical License
    OH State Medical License 2005 - 2008
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

Press Mentions

  • Eyes on the Horizon
    Eyes on the HorizonJune 15th, 2021
  • Palm Desert Resident Meets the Woman Whose Life She Saved with Bone Marrow Transplant
    Palm Desert Resident Meets the Woman Whose Life She Saved with Bone Marrow TransplantJuly 6th, 2021
  • UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
    UC San Diego Health First in Region to Provide Novel Therapy for MelanomaJune 5th, 2024